Table 1.
Physicians’ sociodemographic characteristics, professional experience, and healthcare center characteristics (based on round one)
| Variable | Total (n = 97) | Endocrinology (n = 33) |
Cardiology (n = 22) |
Internal medicine (n = 22) |
Family and community medicine (n = 20) | |
|---|---|---|---|---|---|---|
| Age, years | Mean ± SD | 52.3 ± 9.0 | 49.6 ± 9.5 | 49.6 ± 8.9 | 53.6 ± 8.3 | 58.2 ± 5.1 |
| Median (IQR) | 53.0 (45.0–60.0) | 53.0 (41.0–57.0) | 49.0 (45.0–54.8) | 53.5 (47.0–60.8) | 59.0 (55.0–62.3) | |
| Sex, male | n (%) | 58 (59.8) | 18 (54.5) | 14 (63.6) | 12 (54.5) | 14 (70.0) |
| Years of experience | Mean ± SD | 22.4 ± 9.4 | 20.9 ± 9.8 | 17.6 ± 8.1 | 23.2 ± 9.0 | 29.5 ± 5.6 |
| Median (IQR) | 22.0 (16.0–30.0) | 22.0 (13.0–28.0) | 18 (12.5–20.0) | 20.0 (15.8–331.5) | 30.0 (25.0–32.8) | |
| Number of individuals attended weekly in consultation | Mean ± SD | 88.1 ± (63.6) | 93.3 ± 59.6 | 60.5 ± 39.0 | 37.5 ± 25.7 | 165.8 ± 40.6 |
| Median (IQR) | 75.0 (40.0–125.0) | 80.0 (60.0–100.0) | 50.0 (40.0–67.5) | 27.5 (16.3–60.0) | 150.0 (147.5–200.0) | |
| Percentage of people with a T2D diagnosis | Mean ± SD | 36.9 ± 20.4 | 41.4 ± 21.5 | 31.3 ± 9.1 | 52.4 ± 16.9 | 18.4 ± 13.3 |
| Percentage of people with T2D with high CV risk or established CVD | Mean ± SD | 71.3 ± 28.1 | 69.3 ± 26.4 | 89.7 ± 18.0 | 83.2 ± 15.6 | 41.1 ± 24.6 |
| Percentage of people with T2D with high CV risk or established CVD and a GLP-1 RA prescription (by the responder) | Mean ± SD | 38.7 ± 28.1 | 56.1 ± 23.1 | 20.2 ± 12.4 | 42.0 ± 27.1 | 26.6 ± 16.4 |
| Healthcare center level | ||||||
| Primary care | n (%) | 20 (20.6) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 20 (100) |
| Secondary care | n (%) | 18 (18.6) | 9 (27.3) | 3 (13.6) | 6 (27.3) | 0 (0.0) |
| Tertiary care | n (%) | 59 (60.8) | 24 (72.7) | 19 (86.4) | 16 (72.7) | 0 (0.0) |
| Diabetes unit in the work center | n (%) | 43 (44.3) | 20 (60.6) | 14 (63.6) | 7 (31.8) | 2 (10.0) |
CV cardiovascular, CVD cardiovascular disease, GLP-1 RA glucagon-like peptide 1 receptor agonist, n number, IQR interquartile range, SD standard deviation, T2D type 2 diabetes